Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew N Phillips

Showing results (91-100 of 287) with videos related to

Pageof 29
Sort By:
Plos One|December 23, 2021
The risks and benefits of providing HIV services during the COVID-19 pandemicJohn Stover, Sherrie L Kelly, Edinah Mudimu, et al.
AIDS (London, England)|June 10, 2020
First-line HIV treatment outcomes following the introduction of integrase inhibitors in UK guidelinesKate El Bouzidi, Sophie Jose, Andrew N Phillips, et al.
Antiviral Therapy|May 28, 2005
The relationship between CD4 cell count nadirs and the toxicity profiles of antiretroviral regimensJ Smith Colette, Caroline A Sabin, Fiona C Lampe, et al.
Cancer|June 16, 2004
The changing pattern of Kaposi sarcoma in patients with HIV, 1994-2003: the EuroSIDA StudyAmanda Mocroft, Ole Kirk, Nathan Clumeck, et al.
AIDS (London, England)|May 28, 2010
Ongoing changes in HIV RNA levels during untreated HIV infection: implications for CD4 cell count depletionAndrew N Phillips, Fiona C Lampe, Colette J Smith, et al.
Antiviral Therapy|July 1, 2010
Estimated average annual rate of change of CD4(+) T-cell counts in patients on combination antiretroviral therapyAmanda Mocroft, Andrew N Phillips, Bruno Ledergerber, et al.
Antiviral Therapy|June 27, 2007
Risk of discontinuation of nevirapine due to toxicities in antiretroviral-naive and -experienced HIV-infected patients with high and low CD4+ T-cell countsAmanda Mocroft, Schlomo Staszewski, Rainer Weber, et al.
AIDS Care|August 1, 2023
Behaviour changes following HIV diagnosis among men who have sex with men in the era of treatment as prevention: data from a prospective studyNadia Hanum, Valentina Cambiano, Dejan Loncar, et al.
The Journal of Infectious Diseases|January 25, 2002
A clinically prognostic scoring system for patients receiving highly active antiretroviral therapy: results from the EuroSIDA studyJens D Lundgren, Amanda Mocroft, Jose M Gatell, et al.
AIDS (London, England)|November 10, 2020
All-cause hospitalization according to demographic group in people living with HIV in the current antiretroviral therapy eraSophia M Rein, Fiona C Lampe, Margaret A Johnson, et al.
Pageof 29

Showing results (91-100 of 287) with videos related to

Sort By:
Pageof 29
Plos One|December 23, 2021
The risks and benefits of providing HIV services during the COVID-19 pandemicJohn Stover, Sherrie L Kelly, Edinah Mudimu, et al.
AIDS (London, England)|June 10, 2020
First-line HIV treatment outcomes following the introduction of integrase inhibitors in UK guidelinesKate El Bouzidi, Sophie Jose, Andrew N Phillips, et al.
Antiviral Therapy|May 28, 2005
The relationship between CD4 cell count nadirs and the toxicity profiles of antiretroviral regimensJ Smith Colette, Caroline A Sabin, Fiona C Lampe, et al.
Cancer|June 16, 2004
The changing pattern of Kaposi sarcoma in patients with HIV, 1994-2003: the EuroSIDA StudyAmanda Mocroft, Ole Kirk, Nathan Clumeck, et al.
AIDS (London, England)|May 28, 2010
Ongoing changes in HIV RNA levels during untreated HIV infection: implications for CD4 cell count depletionAndrew N Phillips, Fiona C Lampe, Colette J Smith, et al.
Antiviral Therapy|July 1, 2010
Estimated average annual rate of change of CD4(+) T-cell counts in patients on combination antiretroviral therapyAmanda Mocroft, Andrew N Phillips, Bruno Ledergerber, et al.
Antiviral Therapy|June 27, 2007
Risk of discontinuation of nevirapine due to toxicities in antiretroviral-naive and -experienced HIV-infected patients with high and low CD4+ T-cell countsAmanda Mocroft, Schlomo Staszewski, Rainer Weber, et al.
AIDS Care|August 1, 2023
Behaviour changes following HIV diagnosis among men who have sex with men in the era of treatment as prevention: data from a prospective studyNadia Hanum, Valentina Cambiano, Dejan Loncar, et al.
The Journal of Infectious Diseases|January 25, 2002
A clinically prognostic scoring system for patients receiving highly active antiretroviral therapy: results from the EuroSIDA studyJens D Lundgren, Amanda Mocroft, Jose M Gatell, et al.
AIDS (London, England)|November 10, 2020
All-cause hospitalization according to demographic group in people living with HIV in the current antiretroviral therapy eraSophia M Rein, Fiona C Lampe, Margaret A Johnson, et al.
Pageof 29